Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Cites (399)

Items 201–398 of 398

1. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene
   Tiffany A. Greenwood, John R. Kelsoe · 2003 · Genomics
2. Meta-analysis of thalamic size in schizophrenia
   Lisa C. Konick, Lee Friedman · 2001 · Biological Psychiatry
3. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
   Tohru Ohnuma, Sarah J. Augood, Heii Arai, Peter J. McKenna, Piers C. Emson · 1998 · Molecular Brain Research
4. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
   S.L. Eastwood, Paul J. Harrison · 2003 · Molecular Psychiatry
5. Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study
   Rachel Karry, Ehud Klein, Dorit Ben‐Shachar · 2004 · Biological Psychiatry
6. O-Methylation of Catechol Amines in Vivo
   Julius Axelrod, Siro Senoh, Bernhard Witkop · 1958 · Journal of Biological Chemistry
7. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors
   Bente Pakkenberg · 1993 · Biological Psychiatry
8. Alzheimer's disease: one disorder, too many genes?
   Lars Bertram · 2004 · Human Molecular Genetics
9. Genetic variation in the 22q11 locus and susceptibility to schizophrenia
   Hui Liu, Gonçalo R. Abecasis, Simon Charles Heath, Alyson Knowles, Sandra Demars, Ying‐Jiun Chen, Johannes Lodewikus Roos, Judith L. Rapoport, Joseph A. Gogos, Maria Karayiorgou · 2002 · Proceedings of the National Academy of Sciences
10. Ventricular Enlargement in Poor-Outcome Schizophrenia
    Kenneth L. Davis, Monte S. Buchsbaum, Lina Shihabuddin, Jacqueline Spiegel-Cohen, Michael W. Metzger, Ede Frecska, Richard S.E. Keefe, Peter Powchik · 1998 · Biological Psychiatry
11. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia
    Christine L. Konradi, Stephan Heckers · 2001 · Biological Psychiatry
12. Absence of Neurodegeneration and Neural Injury in the Cerebral Cortex in a Sample of Elderly Patients With Schizophrenia
    Steven Edward Arnold, John Q. Trojanowski, Raquel E. Gur, Peter Blackwell, Liying Han, Catherine Choi · 1998 · Archives of General Psychiatry
13. Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study
    Alessandro Bertolino, Joseph H. Callicott, Igor Elman, Venkata Satyanand Mattay, Gioacchino Tedeschi, Joseph Alan Frank, Alan F. Breier, Daniel R. Weinberger · 1998 · Biological Psychiatry
14. "Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.
    Grier P. Page, Varghese George, R. Go, Patricia Z. Page, D. Allison · 2003 · American Journal of Human Genetics
15. Dendritic Spine Hypoplasticity and Downregulation of Reelin and GABAergic Tone in Schizophrenia Vulnerability
    Erminio Costa, John M. Davis, Dennis R. Grayson, Alessandro Guidotti, George D. Pappas, Christine Pesold · 2001 · Neurobiology of Disease
16. The Human Brain Revisited Opportunities and Challenges in Postmortem Studies of Psychiatric Disorders
    David A. Lewis · 2002 · Neuropsychopharmacology
17. Glial Cells Maintain Synaptic Structure and Function and Promote Development of the Neuromuscular Junction In Vivo
    Linga V. Reddy, Samir Koirala, Yoshie Sugiura, Albert A. Herrera, Chien‐Ping Ko · 2003 · Neuron
18. The DTNBP1 (Dysbindin) Gene Contributes to Schizophrenia, Depending on Family History of the Disease
    Ann Van Den Bogaert, J H Schumacher, Thomas G. Schulze, A Otte, Stephanie Ohlraun, Svetlana Kovalenko, Tim Becker, Jan Freudenberg, Erik Gunnar Jönsson, Marja Mattila‐Evenden et al. · 2003 · The American Journal of Human Genetics
19. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin
    Dawn N. Albertson, Barb Pruetz, Carl J. Schmidt, Donald M. Kuhn, Gregory Kapatos, Michael J. Bannon · 2004 · Journal of Neurochemistry
20. Brain dystrophin, neurogenetics and mental retardation
    Mark F. Mehler · 2000 · Brain Research Reviews
21. Hippocampal Neuron Number in Schizophrenia
    Stephan Heckers · 1991 · Archives of General Psychiatry
22. Replication of 1q42 linkage in Finnish schizophrenia pedigrees
    Jesper Ekelund, William Hennah, Tero Hiekkalinna, Alex N. Parker, Joanne M. Meyer, Jouko K Lönnqvist, Leena Peltonen · 2004 · Molecular Psychiatry
23. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons
    S.L. Eastwood, Paul J. Harrison · 2004 · Schizophrenia Research
24. Identification in 2 Independent Samples of a Novel Schizophrenia RiskHaplotype of the Dystrobrevin Binding Protein Gene (DTNBP1)
    Nigel M. Williams, Anna C Preece, Derek W. Morris, Gillian Spurlock, Nicholas J. Bray, M. Stephens, Nadine Norton, Hywel J. Williams, Mathew Clement, Sarah Dwyer et al. · 2004 · Archives of General Psychiatry
25. The absence of a major Ca ²⁺ signaling pathway in GABAergic neurons of the hippocampus
    Sík, Attila, Hájos, Norbert, Gulácsi, Alexandra, Mody, Istvan, Freund, Tamás F. · 1998 · Proceedings of the National Academy of Sciences
26. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia
    Anthony A. Grace · 1993 · Journal of Neural Transmission
27. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia
    Hamid M. Abdolmaleky · 2003 · Schizophrenia Research
28. Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex
    C Yang · 1999 · Neuropsychopharmacology
29. Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice
    Marko Huotari, Joseph A. Gogos, Maria Karayiorgou, Olli Koponen, Markus Forsberg, Atso Raasmaja, Juha M. T. Hyttinen, Pekka T. Männistö · 2002 · European Journal of Neuroscience
30. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
    H. Jacquet · 2002 · Human Molecular Genetics
31. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders
    Will P. J. M. Spooren, T.M. Ballard, Fabrizio Gasparini, Marianne Amalric, Vincent Mutel, Rudy Schreiber · 2003 · Behavioural Pharmacology
32. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology
    Baaré, Wim F.C, Hulshoff Pol, Hilleke E, Hijman, Ron, Th. Mali, Willem P, Viergever, Max A, Kahn, René S · 1999 · Biological Psychiatry
33. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia
    Marutle, Amelia, Zhang, Xiao, Court, Jennifer, Piggott, Margaret, Johnson, Mary, Perry, Robert, Perry, Elaine, Nordberg, Agneta · 2001 · Journal of Chemical Neuroanatomy
34. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia
    Dahlia W. Zaidel, M M Esiri, Paul J. Harrison · 1997 · American Journal of Psychiatry
35. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
    Jürgen Gallinat, Malek Bajbouj, Thomas Sander, Peter Schlattmann, Ke Xu, Erica Ferro, David A Goldman, Georg Winterer · 2003 · Biological Psychiatry
36. Reduced Gray Matter Volume in Schizophrenia
    Raquel E. Gur, Bruce I. Turetsky, Warren B. Bilker, Ruben C. Gur · 1999 · Archives of General Psychiatry
37. Evidence for Decreased DARPP-32 in the Prefrontal Cortex of Patients With Schizophrenia
    Katherine A. Albert, Hugh C. Hemmings, Anna I. B. Adamo, Steven G. Potkin, Schahram Akbarian, Curt A. Sandman, Carl W. Cotman, William E. Bunney, Paul Greengard · 2002 · Archives of General Psychiatry
38. The Synaptic Hypothesis of Schizophrenia
    William Gordon Frankle, Juan Lerma, Marc A. Laruelle · 2003 · Neuron
39. Calcineurin regulation of neuronal plasticity
    Rachel D. Groth, Robert L. Dunbar, Paul G. Mermelstein · 2003 · Biochemical and Biophysical Research Communications
40. Neuregulin Induces GABAAReceptor Subunit Expression and Neurite Outgrowth in Cerebellar Granule Cells
    Heather I. Rieff, Lori Therese Raetzman, Douglas W. Sapp, Hermes H. Yeh, Ruth E. Siegel, Gabriel Corfas · 1999 · Journal of Neuroscience
41. Yeast two-hybrid screens implicate DISC1 in brain development and function
    J. Kirsty Millar, Sheila Christie, David John Porteous · 2003 · Biochemical and Biophysical Research Communications
42. Schizophrenia
    Daniel J. Luchins · 1979 · Archives of General Psychiatry
43. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain
    Amanda J. Law, Cynthia Shannon Weickert, Thomas M. Hyde, J.E. Kleinman, Paul J. Harrison · 2004 · Neuroscience
44. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
    S L Eastwood, Paul J. Harrison · 2003 · Molecular Psychiatry
45. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype
    Tao Li, Hreinn Stefánsson, Einar Gudfinnsson, Guiqing Cai, X Liu, Robin M. Murray, Valgerður Steinthórsdóttir, Dominique Januel, Vala G Gudnadottir, Hannes Pétursson et al. · 2004 · Molecular Psychiatry
46. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria
    George Kirov, Dobril K. Ivanov, Nigel M. Williams, Anna C Preece, Ivan Nikolov, Radoi Milev, Svetlinka Koleva, Albena Dimitrova, Draga Ivanova Toncheva, Michael C. O’Donovan et al. · 2004 · Biological Psychiatry
47. Smaller Anterior Hippocampal Formation Volume in Antipsychotic-Naive Patients With First-Episode Schizophrenia
    Philip R. Szeszko, Ethan M. Goldberg, Handan Gunduz‐Bruce, Manzar Ashtari, Delbert G. Robinson, Anil K. Malhotra, Todd Lencz, John Bates, DAVID T. CRANDALL, John Michael Kane et al. · 2003 · American Journal of Psychiatry
48. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system
    Christopher G. C. Larminie, Paul R. Murdock, Jean‐Philippe Walhin, Malcolm D. Duckworth, Kendall Blumer, Mark A. Scheideler, Martine J. Garnier · 2004 · Molecular Brain Research
49. β-dystrobrevin, a member of the dystrophin-related protein family
    Derek J. Blake, Ralph Nawrotzki, Nellie Y. Loh, Dariusz C. Górecki, Kay Elizabeth Davies · 1998 · Proceedings of the National Academy of Sciences
50. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes
    Alison Shield, Bianca A. Thomae, Bruce W. Eckloff, Eric D. Wieben, Richard M. Weinshilboum · 2004 · Molecular Psychiatry
51. Volumes of association thalamic nuclei in schizophrenia: a postmortem study
    P. Dános, Bruno Baumann, Andrea Krämer, Hans-Gert Bernstein, Renate Stauch, Dieter Krell, Peter Falkai, Bernhard Bogerts · 2003 · Schizophrenia Research
52. Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines
    Amanda J. Law, Cynthia Shannon Weickert, Thomas M. Hyde, Joel E. Kleinman, Paul J. Harrison · 2004 · American Journal of Psychiatry
53. Cerebral Gray Matter Volume Deficits in First Episode Psychosis
    Robert B. Zipursky, Evelyn K. Lambe, Shitij Kapur, David John Mikulis · 1998 · Archives of General Psychiatry
54. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
    Paul J. Harrison, Sharon L. Eastwood · 1998 · The Lancet
55. Neuregulin 1 and schizophrenia
    Hreinn Stefánsson, Valgerður Steinthórsdóttir, Thorgeir Elís Thorgeirsson, Jeffrey R. Gulcher, Kāri Stefánsson · 2004 · Annals of Medicine
56. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology
    S.L. Eastwood, Amanda J. Law, Ian Everall, Paul J. Harrison · 2003 · Molecular Psychiatry
57. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks
    Robert T. Gerlai, Paul I. Pisacane, Sharon L. Erickson · 2000 · Behavioural Brain Research
58. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat
    Michelle S. Mazei‐Robison, Charles P. Pluto, Bobbi Kirkbride, Elizabeth A. Pehek · 2002 · Brain Research
59. Disturbed Gyrification of the Prefrontal Region in Male Schizophrenic Patients: A Morphometric Postmortem Study
    Kai Thorsten Vogeley, Thomas Schneider-Axmann, Ute Pfeiffer, Ralf Tepest, Thomas A. Bayer, Bernard Bogerts, William G. Honer, Peter Falkai · 2000 · American Journal of Psychiatry
60. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified
    Anjene Musick Addington, Michele Caroline Gornick, Alexandra L. Sporn, Nitin Gogtay, DEANNA K. GREENSTEIN, Marge Lenane, Peter Gochman, Natalie Baker, Rishi Balkissoon, Radhakrishna Vakkalanka et al. · 2004 · Biological Psychiatry
61. Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
    Greene, Robert · 2001 · Hippocampus
62. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11
    Tao Li, David Ball, Jinghua Zhao, Robin M. Murray, X Liu, Pak Chung Sham, David Andrew Collier · 2000 · Molecular Psychiatry
63. Nicotinic α7 Receptor Clusters on Hippocampal GABAergic Neurons: Regulation by Synaptic Activity and Neurotrophins
    Kawai, Hideki, Zago, Wagner, Berg, Darwin K. · 2002 · The Journal of Neuroscience
64. The neuropathological effects of antipsychotic drugs
    Paul J. Harrison · 1999 · Schizophrenia Research
65. A Cysteine-Rich Isoform of Neuregulin Controls the Level of Expression of Neuronal Nicotinic Receptor Channels during Synaptogenesis
    Xia Yang, Yuhung Kuo, Piroska Dévay, Congrong Yu, Lorna W. Role · 1998 · Neuron
66. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia
    Jingyuan Tang, Jian Ping Zhou, Juan Fan, X W Li, Yongyong Shi, N F Gu, Guo Yin Feng, Y L Xing, Junya Shi, Lin He · 2003 · Molecular Psychiatry
67. Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development
    Christopher P. Austin, Betty Ky, Lan Ma, Jill A. Morris, Paul J. Shughrue · 2004 · Neuroscience
68. Schizophrenia: the cellular biology of a functional psychosis
    Gareth Wyn Roberts · 1990 · Trends in Neurosciences
69. Confirming <i>RGS4</i> as a susceptibility gene for schizophrenia
    Morris, Derek W., Rodgers, Alana, McGhee, Kevin A., Schwaiger, Siobhan, Scully, Paul, Quinn, John, Meagher, David, Waddington, John L., Gill, Michael, Corvin, Aiden P. · 2004 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
70. Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals
    Honer, W · 2003 · Neurobiology of Aging
71. The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia
    Terry E. Goldberg, Richard E. Straub, Joseph H. Callicott, Ahmad R. Hariri, Venkata Satyanand Mattay, Llewellyn B. Bigelow, Richard Coppola, Michael F. Egan, Daniel R. Weinberger · 2006 · Neuropsychopharmacology
72. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
    Edwin J. C. G. van den Oord, Patrick F. Sullivan, Y Jiang, Dermot Walsh, F. Anthony O’Neill, Kenneth S. Kendler, Brien P. Riley · 2003 · Molecular Psychiatry
73. Support for RGS4 as a susceptibility gene for schizophrenia
    Nigel M. Williams, Anna C Preece, Gillian Spurlock, Nadine Norton, Hywel J. Williams, Robin G. McCreadie, Paul R. Buckland, Val Sharkey, Kodavali V. Chowdari, Stanley Zammit et al. · 2004 · Biological Psychiatry
74. Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
    Mitsuyuki Matsumoto, Cynthia Shannon Weickert, Senda Beltaifa, Bhaskar S. Kolachana, Jingshan Chen, Thomas M. Hyde, Mary M. Herman, Daniel R. Weinberger, Joel E. Kleinman · 2003 · Neuropsychopharmacology
75. Schizophrenia: a disorder of neurodevelopment?
    Paul J. Harrison · 1997 · Current Opinion in Neurobiology
76. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene ( GRM3 ) with schizophrenia
    Yo Fujii, Hiroki Shibata, Rumiko Kikuta, Chieko Makino, Ayako Tani, Naotsugu Hirata, Atsushi Shibata, Hideaki Ninomiya, Nobutada Tashiro, Yasuyuki Fukumaki · 2003 · Psychiatric Genetics
77. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families
    Hai‐Gwo Hwu, C-M Liu, Cathy S.J. Fann, W.‐C. Ouyang, Sandy F.‐C. Lee · 2003 · Molecular Psychiatry
78. GSK-3 and the neurodevelopmental hypothesis of schizophrenia
    Nitsan Kozlovsky, R.H. Belmaker, Galila Agam · 2002 · European Neuropsychopharmacology
79. Preferential transmission of the high activity allele of COMT in schizophrenia
    Tao Li, Pak Chung Sham, Homero Vallada, Tao Xie, Xiangdong Tang, Robin M. Murray, X. Liu, David Andrew Collier · 1996 · Psychiatric Genetics
80. Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus
    Aiden Peter Corvin, Derek W. Morris, Kevin A. McGhee, Siobhan Schwaiger, Paul J. Scully, J Quinn, David James Meagher, David St Clair, John L. Waddington, Michael Gill · 2004 · Molecular Psychiatry
81. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia
    Stephen J. Glatt, Stephen V. Faraone, Ming T. Tsuang · 2003 · Molecular Psychiatry
82. Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia
    David A. Lewis, Guillermo González‐Burgos · 2000 · Brain Research Bulletin
83. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families
    X Chen, X Wang, F. Anthony O’Neill, Dermot Walsh, Kenneth S. Kendler · 2004 · Molecular Psychiatry
84. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder
    Rebecca S. Devon, Susan Anderson, Peter W. Teague, Paul Burgess, Tiina M. J. Kipari, Colin A M Semple, J. Kirsty Millar, Walter J Muir, V. Murray, Anthony J. Pelosi et al. · 2001 · Psychiatric Genetics
85. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia
    Hans W. Moises, Tómas Zoëga, Irving I. Gottesman · 2002 · BMC Psychiatry
86. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects
    Stewart A. Anderson, David W. Volk, David A. Lewis · 1996 · Schizophrenia Research
87. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality
    Falkai, Peter, Schneider-Axmann, Thomas, Honer, William G · 2000 · Biological Psychiatry
88. Distribution of catechol-O-methyltransferase expression in human central nervous system
    Jiang Hong, Ho Shu-Leong, Xie Tao, Young Lap-Ping · 1998 · Neuroreport
89. A Systematic Genomewide Linkage Study in 353 Sib Pairs with Schizophrenia
    Nigel M. Williams, Nadine Norton, Hywel J. Williams, B. Ekholm, Marian L. Hamshere, Yvonne Lindblom, Kodavali V. Chowdari, A.G. Cardno, Stanley Zammit, Lisa Anne Jones et al. · 2003 · The American Journal of Human Genetics
90. The role of synaptic morphology in neural plasticity: structural interactions underlying synaptic power
    Diano F. Marrone · 2002 · Brain Research Reviews
91. Chromosomal Location and Genomic Structure of the Human Translin-Associated Factor X Gene (TRAX; TSNAX) Revealed by Intergenic Splicing to DISC1, a Gene Disrupted by a Translocation Segregating with Schizophrenia
    J. Kirsty Millar, Sheila Christie, Colin A M Semple, David John Porteous · 2000 · Genomics
92. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele
    Dimitrios Avramopoulos, Nicholas C. Stefanis, Ioanna Hantoumi, Nikolaos Smyrnis, Ioannis Evdokimidis, C. N. STEFANIS · 2002 · Molecular Psychiatry
93. Cerebellar synaptic protein expression in schizophrenia
    S.L. Eastwood, David Cotter, Paul J. Harrison · 2001 · Neuroscience
94. A case control and family based association study of the neuregulin1 gene and schizophrenia
    X Zhao, Y Shi, J Tang, R Tang, L Yu, N Gu, G Feng, S Zhu, H Liu, Y Xing et al. · 2004 · Journal of Medical Genetics
95. Immunocytochemical localization of d-amino acid oxidase in rat brain
    Sandra Moreno, Roberta Nardacci, Annamaria Cimini, Maria Paola Cer` · 1999 · Journal of Neurocytology
96. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia
    Leonid S. Krimer · 1997 · Cerebral Cortex
97. Gray and White Matter Brain Abnormalities in First-Episode Schizophrenia Inferred From Magnetization Transfer Imaging
    Manny S. Bagary, Mark R. Symms, Gareth J. Barker, Stan Mutsatsa, Eileen M. Joyce, María A. Ron · 2003 · Archives of General Psychiatry
98. Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with Schizophrenia
    Robert A. Sweet, Joseph N. Pierri, Sungyoung Auh, Allan R. Sampson, David A. Lewis · 2002 · Neuropsychopharmacology
99. Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population
    J X Tang, Weisheng Chen, Guang He, Jian Ping Zhou, N F Gu, Guo Yin Feng, Lin He · 2003 · Molecular Psychiatry
100. Estimated Neuronal Populations and Volumes of the Hippocampus and Its Subfields in Schizophrenia
     Mary A. Walker, J. Robin Highley, Margaret M. Esiri, Brendan McDonald, Helen C. Roberts, Suzanne P. Evans, Timothy John Crow · 2002 · American Journal of Psychiatry
101. Expression and Intracellular Localization of Catechol O‐methyltransferase in Transfected Mammalian Cells
     Ismo Ulmanen, Johan Peränen, Jukka Tenhunen, Carola Tilgmann, Tuula Karhunen, Pertti Panula, Lilia Bernasconi, Jean‐Piere Aubry, Kenneth H. Lundstrom · 1997 · European Journal of Biochemistry
102. Mitochondrial involvement in schizophrenia and other functional psychoses
     S. A. Whatley, Daniela Curti, Roger M. Marchbanks · 1996 · Neurochemical Research
103. Catechol-O-methyltransferase polymorphisms and schizophrenia
     Hiroshi Kunugi, Homero Vallada, Pak Chung Sham, Farzana Hoda, M J Arranz, Tao Li, S. Nanko, Robin M. Murray, Peter McGuffin, M J Owen et al. · 1997 · Psychiatric Genetics
104. Cortical abnormality in schizophrenia: An in vivo application of the gyrification index
     Jennifer J. Kulynych, Laura F. Luevano, Douglas W. Jones, Daniel R. Weinberger · 1997 · Biological Psychiatry
105. No association with the neuregulin 1 haplotype to Japanese schizophrenia
     Nakao Iwata, Taroh Suzuki, Masashi Ikeda, Tsuyoshi Kitajima, Yoshio Yamanouchi, Toshiya Inada, Norio Ozaki · 2003 · Molecular Psychiatry
106. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF)
     Dawn L. Thiselton, Bradley Todd Webb, Benjamin M. Neale, R. Ribble, F. Anthony O’Neill, Dermot Walsh, Brien P. Riley, Kenneth S. Kendler · 2004 · Molecular Psychiatry
107. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types
     Karl‐Anton Dorph‐Petersen, Joseph N. Pierri, Zhuoxin Sun, Allan R. Sampson, David A. Lewis · 2004 · The Journal of Comparative Neurology
108. The genetics of schizophrenia: glutamate not dopamine?
     David Andrew Collier, Tao Li · 2003 · European Journal of Pharmacology
109. The Neuropathology of the Autism Spectrum Disorders: What Have We Learned?
     Margaret L. Bauman, Thomas L. Kemper · 2003 · Novartis Foundation symposium
110. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study
     Derek W. Morris, Kevin A. McGhee, Siobhan Schwaiger, Paul J. Scully, John Quinn, David James Meagher, John L. Waddington, Michael Gill, Aiden Peter Corvin · 2003 · Schizophrenia Research
111. Cytoarchitecture of the entorhinal cortex in schizophrenia
     M Akil, David A. Lewis · 1997 · American Journal of Psychiatry
112. Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression
     Jubao Duan, Alan R. Sanders, J E Vander Molen, L Martinolich, Bryan J. Mowry, Douglas F. Levinson, Raymond Crowe, Jeremy M. Silverman, Pablo V. Gejman · 2003 · Molecular Psychiatry
113. The Role of ErbB2 Signaling in the Onset of Terminal Differentiation of OligodendrocytesIn Vivo
     Ju Young Kim, Qin Sun, Michael Oglesbee, Sung Ok Yoon · 2003 · Journal of Neuroscience
114. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population
     Sylvia Bort Martí, Sven Cichon, Peter Propping, Markus Maria Nöthen · 2001 · American Journal of Medical Genetics
115. Defining the course of brain structural change and plasticity in schizophrenia
     Lynn E. DeLisi · 1999 · Psychiatry Research Neuroimaging
116. Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
     Elizabeth M. Tunbridge, Philip W. J. Burnet, Monsheel Sodhi, Paul J. Harrison · 2003 · Synapse
117. Genetic linkage and association between chromosome 1q and working memory function in schizophrenia
     Timothy L. Gasperoni, Jesper Ekelund, MATTI O. HUTTUNEN, Christina G.S. Palmer, Annamari Tuulio‐Henriksson, Jouko K Lönnqvist, Jaakko A. Kaprio, Leena Peltonen, Tyrone D. Cannon · 2002 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
118. Alternative splicing in the nervous system: an emerging source of diversity and regulation
     Christopher J. Lee, Kris Irizarry · 2003 · Biological Psychiatry
119. Meta-analysis of brain weight in schizophrenia
     Paul J. Harrison, Nick Freemantle, John Richard Geddes · 2003 · Schizophrenia Research
120. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia
     T. J. Cullen, Mary A. Walker, Nick Parkinson, Rebecca Craven, Timothy John Crow, Margaret M. Esiri, Paul J. Harrison · 2003 · Schizophrenia Research
121. Rett Syndrome - an update
     K. A. Jellinger · 2003 · Journal of Neural Transmission
122. Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells
     Karen Luyt, Anikó Váradi, Elek Molnár · 2003 · Journal of Neurochemistry
123. Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects
     Judith Gault, Janet A. Hopkins, Ralph Berger, Carla J. Drebing, Judith Logel, Catherine Walton, Margaret Short, Ruby Vianzon, Ann Olincy M. D, Randal G. Ross et al. · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
124. The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls
     Alan J. Cross, Timothy John Crow, W. S. Killpack, A. Longden, Frank Owen, G. J. Riley · 1978 · Psychopharmacology
125. Up-regulation of the D1 Dopamine Receptor–Interacting Protein, Calcyon, in Patients With Schizophrenia
     Phil‐Ok Koh, Clare M. Bergson, Ashiwel S. Undie, Patricia S. Goldman‐Rakic, Michael S. Lidow · 2003 · Archives of General Psychiatry
126. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation
     Mellissa M. C. DeMille, Judith R. Kidd, Valeria Ruggeri, Meg A. Palmatier, David A Goldman, Adekunle Odunsi, Friday Ebhodaghe Okonofua, Elena L. Grigorenko, Leslie Olmstead Schulz, Batsheva Bonné et al. · 2002 · Human Genetics
127. Nicotinic Receptors on Local Circuit Neurons in Dentate Gyrus: A Potential Role in Regulation of Granule Cell Excitability
     Charles J. Frazier, Ben W. Strowbridge, Roger L. Papke · 2003 · Journal of Neurophysiology
128. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons
     Gavin P. Reynolds, Clare L. Beasley, Z. J. Zhang · 2002 · Journal of Neural Transmission
129. DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain
     Christopher P. Austin, Lei Ma, Betty Ky, Jill A. Morris, Paul J. Shughrue · 2003 · Neuroreport
130. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus
     Sarah M. Richardson-Burns, Vahram H. Haroutunian, Kenneth L. Davis, Stanley J. Watson, James H. Meador‐Woodruff · 2000 · Biological Psychiatry
131. Regional expression of RGS4 mRNA in human brain†
     Holly A. Erdely, Robert A. Lahti, Mary B. Lopez, Carol S. Myers, Rosalinda C. Roberts, Carol A. Tamminga, Michael W. Vogel · 2004 · European Journal of Neuroscience
132. The amyloid hypothesis: let sleeping dogmas lie?
     Glenda M. Bishop, Stephen R. Robinson · 2002 · Neurobiology of Aging
133. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration
     Clare L. Beasley, David Cotter, Ian Everall · 2002 · Molecular Psychiatry
134. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia
     Dominic G. Fannon, Andrew Simmons, Lakshika Tennakoon, Séamus O’Ceallaigh, Alexander Luke Sumich, Victor C. K. Doku, Carl Shew, Tonmoy Sharma · 2003 · Biological Psychiatry
135. Dynamic Expression ofRGS4in the Developing Nervous System and Regulation by the Neural Type-Specific Transcription Factor Phox2b
     Nicolas Grillet, Véronique Dubreuil, Héloïse D. Dufour, Jean‐François Brunet · 2003 · Journal of Neuroscience
136. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population
     Fanggeng Zou, Chao Li, Shiwei Duan, Yonglan Zheng, Niufan Gu, Guoyin Feng, Yang-ling Xing, Jianguo Shi, Lin He · 2004 · Schizophrenia Research
137. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease
     Malahat T. Mousavi, Ewa Hellström‐Lindahl, Z.-Z Guan, Ke-ren Shan, Rivka Ravid, Agneta K. Nordberg · 2003 · Neuroscience
138. Molecular characterization and localization of human metabotropic glutamate receptor type 3
     ANDREW J. MAKOFF, Filippo Volpe, Rosalia Lelchuk, Kathleen A. Harrington, Piers C. Emson · 1996 · Molecular Brain Research
139. Nicotinic Modulation of Mesoprefrontal Dopamine Neurons: Pharmacologic and Neuroanatomic Characterization
     Tony Peter George, Christopher D. Verrico, Marina R. Picciotto, Robert Howard Roth · 2000 · Journal of Pharmacology and Experimental Therapeutics
140. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia
     Erik Gunnar Jönsson, Rolf Kaiser, J rgen Brockm ller, Vishwajit Laxmikant Nimgaonkar, Marc‐Antoine Crocq · 2004 · Psychiatric Genetics
141. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study
     Sutisa Nudmamud‐Thanoi, Lindsay M. Reynolds, Gavin P. Reynolds · 2003 · Biological Psychiatry
142. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects
     Jeremy Micah Crook, M Akil, Bill Law, T M Hyde, Joel E. Kleinman · 2002 · Molecular Psychiatry
143. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia [published erratum appears in Am J Psychiatry 1997 Aug;154(8):1180]
     Ross J. Baldessarini, James D. Hegarty, E. D. Bird, Francine Mary Benes · 1997 · American Journal of Psychiatry
144. The dynamic organization of postsynaptic proteins: translocating molecules regulate synaptic function
     Akihiro Inoue, Shigeo Okabe · 2003 · Current Opinion in Neurobiology
145. Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system
     Anne Kästner, Philippe Anglade, C. Bounaix, Philippe Damier, France Javoy-Agid, Norbert Bromet, Yves Agid, Étienne C. Hirsch · 1994 · Neuroscience
146. Association between PRODH and schizophrenia is not confirmed
     Hywel J. Williams, Nigel M. Williams, Gillian Spurlock, Nadine Norton, Dobril K. Ivanov, Robin G. McCreadie, Anna C Preece, Val Sharkey, Siân Jones, Stanley Zammit et al. · 2003 · Molecular Psychiatry
147. Low Medial and Lateral Right Pulvinar Volumes in Schizophrenia: A Postmortem Study
     J. Robin Highley, Mary A. Walker, Timothy John Crow, Margaret M. Esiri, Paul J. Harrison · 2003 · American Journal of Psychiatry
148. Proton magnetic resonance spectroscopy in schizophrenia
     Alessandro Bertolino, Daniel R. Weinberger · 1999 · European Journal of Radiology
149. The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems
     Fallon, James H., Opole, Isaac O., Potkin, Steven G. · 2003 · Clinical Neuroscience Research
150. Neuregulin-1 Isoforms Are Differentially Expressed in the Intact and Regenerating Adult Rat Nervous System
     Gabriele Kerber, Robert Streif, Franz‐Werner Schwaiger, Georg W. Kreutzberg, Gerhard Hager · 2003 · Journal of Molecular Neuroscience
151. Schizophrenia (2nd edn). Edited by Steven R. Hirsch & Daniel R. Weinberger Oxford: Blackwell. 2003. 768 pp. £89.50 (hb). ISBN 0 632063882
     A. M. Denman · 2004 · The British Journal of Psychiatry
152. Variation at the APOE −491 promoter locus is associated with altered brain levels of apolipoprotein E
     Simon Matthew Laws, Eugene Hone, Kevin Taddei, C Harper, Brian Dean, Catriona McClean, Colin Louis Masters, Nicola T. Lautenschlager, Sam Gandy, Ralph Nigel Martins · 2002 · Molecular Psychiatry
153. Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
     Daniel H. Mathalon, Judith L. Rapoport, Kenneth L. Davis, John Harrison Krystal · 2003 · Archives of General Psychiatry
154. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia
     Hywel J. Williams, Nigel M. Williams, Gillian Spurlock, Nadine Norton, Stanley Zammit, George Kirov, Michael John Owen, Michael C. O’Donovan · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
155. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective ?/? antagonist in the [35S]-GTP-?-S functional binding assay
     Dana V. Romero, John S. Partilla, Qaio‐Xi Zheng, Simone O. Heyliger, Qing Ni, Kenner C. Rice, Josephine Y. Lai, Richard B. Rothman · 1999 · Synapse
156. Variability in the Human Entorhinal Region May Confound Neuropsychiatric Diagnoses
     Helmut Heinsen, E. Gössmann, U. Rüb, Wolfgang Eisenmenger, Mark A. Bauer, Gerd Ulmar, B. Bethke, Michael Schüler, H.-P. Schmitt, M. Götz et al. · 1996 · Cells Tissues Organs
157. Neuropathology of schizophrenia
     Paul J. Harrison · 2005 · Psychiatry
158. No increased incidence of Alzheimer’s disease in elderly schizophrenics
     K. Jellinger, E. Gabriel · 1999 · Acta Neuropathologica
159. Opposite modulation of regulators of G protein signalling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum
     Muriel Geurts, Emmanuel Hermans, Jean‐Marie Maloteaux · 2002 · Neuroscience Letters
160. Size of hippocampal pyramidal neurons in schizophrenia
     J. Robin Highley, Mary A. Walker, B. McDonald, Timothy John Crow, Margaret M. Esiri · 2003 · The British Journal of Psychiatry
161. Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression
     Jessie Theuns · 2003 · Human Molecular Genetics
162. Proline-induced inhibition of glutamate release in hippocampal area CA1
     Susan M. Cohen, J. Victor Nadler · 1997 · Brain Research
163. Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters
     Nancy A. Muma, Ramesh Mariyappa, Kyle Williams, John Michael Lee · 2002 · Synapse
164. Isolated familial adrenocorticotropin deficiency: Prenatal diagnosis by maternal plasma estriol assay
     Georges Malpuech, P Vanlieferinghen, Pierre Dechelotte, Jacqueline Gaulme, André Labbé, Florence Guiot, John M. Optiz, James F. Reynolds · 1988 · American Journal of Medical Genetics
165. Presynaptic Proteins and Schizophrenia
     William G. Honer, Clint E. Young · 2004 · International review of neurobiology
166. Proline, glutamate and glutamine metabolism in mouse brain synaptosomes
     Jeffery Lee Johnson, Eugene Roberts · 1984 · Brain Research
167. Cognitive Impairment in Elderly Schizophrenia: A Dementia (Still) Lacking Distinctive Histopathology
     Steven Edward Arnold, John Q. Trojanowski · 1996 · Schizophrenia Bulletin
168. A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population
     Jinbo Fan, Jie Ma, Chang-Shun Zhang, Junxia X. Tang, Niufan Gu, Guo-Ying Feng, David St Clair, Lin He · 2003 · Neuroscience Letters
169. Neuregulin-1β modulates in vivo entorhinal–hippocampal synaptic transmission in adult rats
     Sanya Roysommuti, Steven Lewis Carroll, James Michael Wyss · 2003 · Neuroscience
170. The neuropathology of schizophrenia : progress and interpretation
     Paul J. Harrison, Gareth Wyn Roberts · 2000
171. Regio entorhinalis in Schizophrenia: More Evidence for Migrational Disturbances and Suggestions for a New Biological Hypothesis
     S. Kovalenko, Ann Kathrin Bergmann, T. Schneider-Axmann, I Ováry, Katalin Majtényi, László Havas, William G. Honer, Bernhard Bogerts, Peter Falkai · 2003 · Pharmacopsychiatry
172. Neuregulin Signaling via ErbB Receptor Assemblies in the Nervous System
     Sean Patrick Murphy, Randy Krainock, Muly Tham · 2002 · Molecular Neurobiology
173. The brain in schizophrenia.
     María A. Ron, Ian Harvey · 1990 · Journal of Neurology Neurosurgery & Psychiatry
174. Failure to find association between PRODH deletion and schizophrenia
     Tsuyuka Ohtsuki, Syunsuke Tanaka, Hiroki Ishiguro, Eiichi Tanabe, Kazuo Yara, Tatsunobu Okubo, Sakae Takahashi, Masato Matsuura, Teiichiro Sakai, Mariko Muto et al. · 2003 · Schizophrenia Research
175. The Molecular Genetics of Schizophrenia
     Michael C. O’Donovan, Michael J. Owen · 1996 · Annals of Medicine
176. Gene Targeting Reveals Multiple Essential Functions of the Neuregulin Signaling System during Development of the Neuroendocrine and Nervous Systems
     Steven A. Crone, Kuo‐Fen Lee · 2002 · Annals of the New York Academy of Sciences
177. Neuropathology of Schizophrenia
     Paul J. Harrison, Donald Lewis · 2003
178. The Neuropathology of Schizophrenia: Progress and Interpretation
     Steven Andrew Chance · 2001 · Neuropathology and Applied Neurobiology
179. Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia
     Manuel Fernando Casanova, Brian Rothberg · 2002 · Schizophrenia Research
180. Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis
     Marjan Kromkamp, Harry B. M. Uylings, Marten P. Smidt, Anita J. C. G. M. Hellemons, J. Peter H. Burbach, René S. Kahn · 2003 · Archives of General Psychiatry
181. Brains at risk of schizophrenia
     Paul J. Harrison · 1999 · The Lancet
182. Glutamate receptor genes
     H. Schiffer · 2002 · Molecular Neurobiology
183. Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique
     Robert K. McClure, Jeffrey Alan Lieberman · 2003 · Current Opinion in Psychiatry
184. Brain Imaging in Schizophrenia
     Peter Francis Liddle, Christos Pantelis · 2003
185. Neuregulins and the Shaping of Synapses
     Miwako Ozaki · 2001 · The Neuroscientist
186. Mutation analysis of the human dystrobrevin-binding protein 1 gene in schizophrenic patients
     Hsiao‐Mei Liao · 2004 · Schizophrenia Research
187. Gliosis and its Implications for the Disease Process
     G.W. Roberts, Paul J. Harrison · 2000
188. The Neuropathology of Schizophrenia
     2000
189. The Neuropathology of Dementia, 2nd ed
     Kimmo J. Hatanpaa · 2005 · Archives of Neurology
190. Disorders of synaptic plasticity and schizophrenia
     John Smythies · 2004
191. Schizophrenia and its dementia
     Paul J. Harrison · 2004 · Cambridge University Press eBooks
192. Perspectives from other Diseases and Lesions
     Margaret M. Esiri, R.C.A. Pearson · 2000
193. A Sceptical View of the Neuropathology of Schizophrenia
     Siew Eng Chua, Peter J. McKenna · 2000
194. Atypical antipsychotics preferentially occupy caudate nucleus D2/D3 receptors within the striatum: A voxel-based analysis
     James M. Stone, Rodrigo A. Bressan, Kjell Erlandsson, G. Davies, Peter Josef Ell, Lyn S. Pilowsky · 2004 · UCL Discovery (University College London)
195. The nicotinic receptors in the human brain
     Agneta K. Nordberg · 2002 · European Neuropsychopharmacology
196. Structural Abnormalities of Subicular Dendrites in Subjects With Schizophrenia and Mood Disorders: Preliminary Findings
     Rosoklija, Gorazd, Toomayan, Glen, Ellis, Steven P., Keilp, John, Mann, J. John, Latov, Norman, Hays, Arthur P., Dwork, Andrew J. · 2000 · Archives of General Psychiatry
197. Untitled work
     Volkow · 1999 · 10.1002/(sici)1098-2396(199901)31:1
198. Twin studies of schizophrenia: From bow-and-arrow concordances to Star Wars Mx and functional genomics
     Cardno, Alastair G., Gottesman, Irving I. · 2000 · American Journal of Medical Genetics